Hypoglycemia clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
VX-880 and VX-017 in Participants With Type 1 Diabetes
open to eligible people ages 18-65
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion and VX-017 infusion in participants with type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.
at UCSF
Last updated: